← Browse by Condition
Medical Condition

bone loss

Total Trials
7
Recruiting Now
7
Trial Phases
EARLY_Phase 1, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for bone loss sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — bone loss Clinical Trials

How many clinical trials are currently recruiting for bone loss?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for bone loss, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for bone loss?
bone loss research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a bone loss clinical trial?
Eligibility criteria for bone loss trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Phase 3
1
Top Sponsors
German Federal Institute for Risk Assessment 1 trial
Istituto Ortopedico Rizzoli 1 trial
Cho Ray Hospital 1 trial
Menoufia University 1 trial
Texas A&M University 1 trial

Recruiting Clinical Trials

NCT06323538
Recruiting
Cohort Study on Plant-based Diets (COPLANT Study)
Enrollment
6,000 pts
Location
Austria, Germany
Sponsor
German Federal Institute for R...
View Trial →
NCT06527664
Recruiting
Innovative Technologies for Salvage Procedures of Failed Treatments of Osteoarthritis: Biomimetics Solutions (CustomPN)
Enrollment
15 pts
Location
Italy
Sponsor
Istituto Ortopedico Rizzoli
View Trial →
NCT04449211 EARLY_Phase 1
Recruiting
The Effectiveness in the Treatment of Long Bone Defect Using 3D-printed Implant
Enrollment
10 pts
Location
Vietnam
Sponsor
Cho Ray Hospital
View Trial →
NCT07093853
Recruiting
Mandibular Overdentures Retained by Four Locator Attachments Versus Four-Implant Bar Attachments
Enrollment
22 pts
Location
Egypt
Sponsor
Menoufia University
View Trial →
NCT06489873
Recruiting
Lutein, Zeaxathin, and Fish Oil Supplementation
Enrollment
80 pts
Location
United States
Sponsor
Texas A&M University
View Trial →
NCT05918029 Phase 2, Phase 3
Recruiting
Bone in CKD Alkali Response (BICARb Pilot Trial)
Enrollment
103 pts
Location
United States
Sponsor
Albert Einstein College of Med...
View Trial →
NCT05701254
Recruiting
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
Enrollment
80 pts
Location
United States
Sponsor
Creighton University
View Trial →

Related Conditions

dietary exposure (1) diabetes mellitus type 2 (1) cardiovascular diseases (1) sustainability (1) exposure (1) obesity (1) vitamin deficiency (1) mineral deficiency (1) hip prosthesis infection (1) arthroplasty complications (1) defect limb (1) cognitive performance (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology